• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2026, Vol. 28 ›› Issue (5): 837-844.DOI: 10.3969/j.issn.1671-2587.2026.05.023

Previous Articles     Next Articles

Research Status of Breast Milk-Derived Alloantibody-Mediated Hemolytic Disease of the Fetus and Newborn

MIYESSAR Anwar1, QIU Jin2, LI Fei2, CHEN Wei2   

  1. 1Department of Blood Transfusion, People's Hospital of Xinjiang Uygur Autonomous Region Bainiaohu Hospital (The Second Affiliated Hospital of Xi'an Jiaotong University Xinjiang Hospital), Urumqi 830022;
    2Department of Blood Transfusion, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830001
  • Received:2026-09-02 Revised:2026-09-18 Online:2026-10-20 Published:2026-11-11

Abstract: The classic pathogenesis of hemolytic disease of the fetus and newborn (HDFN) is that maternal IgG isoantibody is transported into fetal circulation through placental FcRn, which causes immune damage of fetal red blood cells. This mechanism can explain the intrauterine and early postnatal manifestations of most children, but there are limitations in explaining that some children still have persistent or delayed hemolysis several weeks after birth. Case reports in recent years suggest that red blood cell alloantibodies in breast milk may be absorbed into the circulation through the neonatal intestine and participate in the maintenance of postpartum hemolysis. Based on the summary of existing cases, this paper reviews the source of breast milk antibody, the physiological basis of neonatal intestinal absorption, the clinical characteristics, detection methods and causal judgment of related cases. Detection of breast milk alloantibodies currently relies on serological methods, and sample processing, titer reporting, and pathogenic thresholds all lack standardization. From the mechanism point of view, breast milk antibody is more likely to play the role of "maintaining attack" and prolong the course of hemolysis during the window period when placental antibody has not been cleared, rather than starting HDFN independently. The existing evidence is not enough to support the classification of antibody-mediated hemolysis in breast milk as an independent fifth pathogenic mechanism. Prospective cohort study is necessary in the future to clarify its clinical incidence and establish standardized detection and intervention strategies.

Key words: Hemolytic disease of the fetus and newborn, Breast milk, Alloantibody, FcRn

CLC Number: